A transparent smart contact lens embedded with microscopic circuits and electrodes.
Depression treatment has long relied on daily medication or invasive psychiatric procedures to stimulate brain cells. Now, a team of South Korean researchers has engineered a radical alternative. They have developed a smart contact lens capable of treating depression through targeted electrical stimulation.
A transparent smart contact lens embedded with microscopic circuits and electrodes.
Microchips and Electrodes in the Eye
To the naked eye, the device looks like a standard transparent contact lens. Under a microscope, it reveals a microscopic antenna and micrometer-sized electrodes.
The creators built all the internal components using highly flexible, transparent materials. This ensures the embedded technology does not obstruct or alter the user’s vision in any way.
The treatment mechanism relies on precise neural targeting. The lens emits two high-frequency currents that meet inside the eye and convert into a single low-frequency current at the retina.
This current then travels as an electrical signal through the optic nerve to directly stimulate the hippocampus and prefrontal cortex. These are the two primary brain regions that malfunction in patients dealing with depression.
“These electrical signals are completely safe for the eyes,” the scientists confirmed. “They stimulate exclusively the retina and do not cause any pain or discomfort to the patient.”
Matching Medication in 30 Minutes a Day
The research team first tested the lens in a laboratory setting on mice exhibiting symptoms of depression. The treatment regimen required only 30 minutes of wear per day over a three-week period.
Researchers then analyzed the neurological data using machine learning technology. The results showed that mice subjected to the lens therapy no longer shared any similarities with the depressed control group.
Instead, their brain patterns perfectly matched those of entirely healthy mice, mimicking the full effect of pharmaceutical antidepressants without the systemic side effects.
Human Clinical Trials Approaching
Driven by these highly promising laboratory results, the South Korean research team is rapidly moving forward with the next phase of development.
Official clinical trials on human subjects are scheduled to begin within the next three years.
If successful, this technology will offer a massive shift in mental health care. It would replace heavy medical treatments with an invisible, 30-minute daily routine that patients can manage on their own.
